AzTrials
AzTrials

Thoracic TraumaNCT07822191

The Predictive Value of Chest Trauma Score and Thoracic Trauma Severity Score in Thoracic Trauma Patients

An observational study of Thoracic Trauma and Blunt Trauma, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this prospective study is Comparing the diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score in predicting morbidity and mortality. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Thoracic Trauma, Blunt Trauma
How many people
60 participants
Where
1 siteEgypt
Study dates
30 Sep 2023to 30 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: All chest trauma patients

Who may be able to join

  • Age ≥18 years old.
  • All chest trauma patients

Who cannot join

  • Age < 18 years old.
  • Patients with chest disease

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tanta University

    Tanta

Other trials in Egypt

About this study

Official title: The Predictive Value of Chest Trauma Score (CTS) and Thoracic Trauma Severity Score (TTSS) in Thoracic Trauma Patients

The aim of this prospective study is Comparing the diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score in predicting morbidity and mortality.

Read the detailed description

Trauma has been recognized as a leading cause of death and disability worldwide over the past few decades. Thoracic trauma is the third most common traumatic death, after head and spinal cord injury. The incidence of chest trauma is reported 10% of trauma admissions and mortality rate is variable ranging from about 10% to 60% . Trauma to thoracic region has a wide spectrum from chest wall injury to vital organs within the thoracic cavity. Thoracic injuries may be penetrating or blunt and management varies from conservative to invasive . Early accurate grading of chest injury severity is decisive for the clinical course of multiple trauma patients. The severity of chest trauma influences decision making in multiple trauma in terms of timing and priority of surgical interventions (early total care versus damage control) in order to avoid posttraumatic complications . Chest trauma can be classified as either blunt or penetrating type. Penetrating chest wounds are those in which an object penetrates the chest wall and creates an opening into the thoracic cavity. These wounds mostly result from stabbings, gunshot wounds and blast injuries . Blunt trauma to the chest occurs as a result of a force that is propelled onto the chest wall but does not leave an open wound. Motor vehicle accidents account for 90% of the entire blunt chest trauma, other possible causes include falls, crush injuries, sports injuries and acts of violence . chest wall injuries typically make breathing very painful; patients often limit inspiration (splinting). A common complication of splinting is atelectasis, which can lead to hypoxemia, pneumonia, or both . The aim of this prospective study is Comparing the diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score in predicting morbidity and mortality.

Keywords
Thorax Trauma Severity Score, chest Trauma Score, Trauma, Thoracic Trauma Patients
Medical subject headings
Wounds, Nonpenetrating, Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07822191
Study groupRoleWhat they receive
chest trauma patientschest trauma patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score to predict mortality.

    Chest Trauma Scoring (CTS):

    The Chest Trauma Scoring is composed of four different components with a point system assigned:

    • Age.
    • Pulmonary contusion.
    • Number of rib fractures.
    • The presence of bilateral rib fracture. The TTSS score includes five parameters (PaO2/FiO2, Rib fractures, Lung contusion, Pleural injuries) and the score ranged from 0 to 25 points.

    Measured: 18 days

Secondary outcomes (1)
  1. Need and duration of mechanical ventilation

    Measured: 18 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2026
  2. Study start30 Sep 2023
  3. Primary completion30 Oct 2025
  4. Study completion30 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07822191
Sponsor's protocol ID
36265MD143/9/23
Status last verified
Sep 2023
First submitted
10 Sep 2026
Last updated
16 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: it will be available if it needed

Questions about this trial

What is this clinical trial studying?

An observational study of Thoracic Trauma and Blunt Trauma, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The diagnostic accuracy of chest Trauma Score and Thoracic Trauma Severity Score to predict mortality. (time frame: 18 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in